# US 2021/0228822 A1 · Nebulizer and Container

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0228822 A1
- Document ID: US20210228822A1
- Status: Published application
- Kind: A1
- Application number: 17/051,382
- Filed: 2019-05-03
- Published: 2021-07-29
- Earliest claimed: 2018-05-04
- Assignees: Boehringer Ingelheim International GmbH
- Applicants: Boehringer Ingelheim International GmbH
- Inventors: Stephen Terence DUNNE; Dana HUESCH; Peter Rolf Werner LANGGUTH
- Web page: https://patentgrep.com/patent/US20210228822A1

## CPC

- A61M 11/007: {Syringe-type or piston-type sprayers or atomisers}
- A61F 9/0008: {Introducing ophthalmic products into the ocular cavity or retaining products therein (putting in contact lenses A61F9/0061; introducing or retaining media in cavities of the body in general A61M31/00)}
- A61K 9/0078: {for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions}
- A61K 9/127: Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K 47/24: containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A61K 47/28: Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
- A61M 15/0065: {Inhalators with dosage or measuring devices (A61M15/0028 takes precedence; dosage devices incorporated in aerosol cans B65D83/52)}
- B05B 9/0822: {a discharge device being fixed to the container}
- B05B 17/00: Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups (dropping or releasing powdered, liquid or gaseous matter in flight B64D1/16)
- A61K 9/0048: {Eye, e.g. artificial tears}
- A61K 9/1075: {Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers (A61K9/0026 takes precedence)}
- A61K 31/58: containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin (digitoxin {A61K31/7048})
- A61M 15/0035: {Piercing means}
- A61M 2205/071: hand operated
- B05B 1/26: with means for mechanically breaking-up or deflecting the jet after discharge, e.g. with fixed deflectors; Breaking-up the discharged liquid or other fluent material by impinging jets
- B05B 11/0054: {Cartridges, i.e. containers specially designed for easy attachment to or easy removal from the rest of the sprayer (attachment arrangements between pump and container B05B11/1043)}
- B05B 11/026: {Membranes separating the content remaining in the container from the atmospheric air to compensate underpressure inside the container}
- B05B 11/028: {Pistons separating the content remaining in the container from the atmospheric air to compensate underpressure inside the container}
- B05B 11/1091: {being first hold in a loaded state by locking means or the like, then released (B05B11/1092 takes precedence)}
- B05B 15/40: Filters located upstream of the spraying outlets
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- B05B: SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES (spray-mixers with nozzles B01F25/72; processes for applying liquids or other fluent materials to surfaces by spraying B05D)

## Abstract

A system includes a nebulizer for nebulizing a fluid from a container and such a container containing a fluid and are proposed. The fluid is a non-newtonian fluid, in form of a suspension or emulsion or a liposomal fluid or a gel. The nebulizer includes a fluid pump for withdrawing the fluid in doses from the container and pressurizing the respective doses for nebulization through nozzle channels having a hydraulic diameter in the range of 3 to 20 microns at an operational pressure of 5 to 250 MPa.

## Claims

### Claim 1

A system, comprising:
a nebulizer (1) for nebulizing a fluid (2) and a container (3) containing multiple doses of the fluid (2), wherein the nebulizer (1) comprises:
a fluid pump (5) for withdrawing a dose of the fluid (2) from the container (3) and pressurizing the respective dose for nebulization with operational pressure of one of: (i) 5 to 250 MPa, and (ii) 10 to 50 MPa, and
a microstructured component forming a nozzle (12) with nozzle channels (12d) having a hydraulic diameter in the range of one of: (i) 3 to 20 microns, (ii) 4 to 12 microns, and (iii) 5 to 8 microns,
wherein the fluid (2) that at room temperature the fluid (2) has a viscosity at rest of more than one of: (i) 1.7*10−3 Pascal seconds (1.7 centipoise), and (ii) more than 0.1 Pascal seconds (10 centipoise), and the fluid (2) has a shear-thinning behavior.

### Claim 2 (depends on 1)

The system according to claim 1, wherein the fluid (2), which is a structured fluid, comprises a carrier liquid which at room temperature has a viscosity of up to 1.6*10−3 Pascal seconds (1.6 centiPoise), wherein the carrier liquid is water or ethanol or a mixture of water and ethanol.

### Claim 3 (depends on 1)

The system according to claim 1, wherein the fluid (2) is a suspension of nanoparticles.

### Claim 4 (depends on 3)

The system according to claim 3, wherein the nanoparticles comprising an active ingredient such as a beta adrenergic agonists or a glucocorticosteroid.

### Claim 5 (depends on 3)

The system according to claim 3, wherein the nanoparticles have a concentration of up to 10%, preferably up to 7%, and in particular more than 1% in the fluid (2).

### Claim 6 (depends on 1)

The system according to claim 1, wherein the fluid (2) is an emulsion, in particular an “oil-in-water”-emulsion.

### Claim 7 (depends on 1)

The system according to claim 1, wherein the fluid (2) is a liposomal fluid.

### Claim 8 (depends on 7)

The system according to claim 7, wherein the fluid (2) comprises liposomes or lipid droplets or lipid particles wherein the liposomes or lipid droplets or lipid particles comprise a dissolved or embedded active ingredient.

### Claim 9 (depends on 7)

The system according to claim 7, wherein the liposomal fluid comprises a physiological lipid, in particular a phospholipid, preferably lecithine or a mixture of lecithine and cholesterol.

### Claim 10 (depends on 1)

The system according to claim 1, wherein the fluid (2) comprises less than 17% glycerin, in particular less than 10% glycerin or most preferably less than 1% or no glycerin.

### Claim 11 (depends on 1)

The system according to claim 1, wherein the fluid (2) is a gel or comprises a gelling agent, in particular wherein the fluid (2) contains 8.5% or less gelling agent, preferably less than 2% gelling agent.

### Claim 12 (depends on 1)

The system according to claim 1, wherein the container (3) comprises a variable or collapsible or compressible volume (4) containing the fluid (2).

### Claim 13 (depends on 12)

The system according to claim 12, wherein the container (3) comprises a collapsible bag as a collapsible volume (4) containing the fluid (2).

### Claim 14 (depends on 12)

The system according to claim 12, wherein the container (3) comprises a rigid casing (20) and a fluid piston (28) moveable therein forming a space for directly receiving the fluid (2) or the variable or compressible volume (4) containing the fluid (2).

### Claim 15 (depends on 12)

The system according to claim 12, wherein the system comprises a means to pressurizing the fluid (2) in the container (3) or a means to apply pressure to the variable or collapsible or compressible volume (4) containing the fluid (2), in particular wherein the means pressurizes the fluid (2) (in addition to the ambient pressure) with a pressure of to 5000 to 3*105 Pascal (0.05 to 3 bars) or can apply a pressure of 5000 to 3*105 Pascal (0.05 to 3 bars), preferably 20000 to 105 Pascal or 105 to 2*105 Pascal (0.2-1 bar or 1-2 bars), during the withdrawal of fluid (2) from the container (3).

### Claim 16 (depends on 15)

The system according to of claim 15, wherein the means to apply pressure to the variable or collapsible or compressible volume (4) is configured to apply the pressure in the direction of a fluid outlet of the container (3) and/or in the direction of a fluid entrance, in particular a conveying tube (9), into the nebulizer (1) during withdrawal of the fluid (2).

### Claim 17 (depends on 15)

The system according to claim 15, wherein the means is formed by or comprises an air pump (30) associated to the container (3) for pressurizing the fluid (2) in the container (3) to help withdrawing the fluid (2) in doses from the container (3).

### Claim 18 (depends on 17)

The system according to claim 17, wherein during use of the nebulizer (1), the air pump (30) and the fluid pump (5) pressurize alternately, in particular the air pump (30) pressurizes air when tensioning or loading the nebulizer (1) and the fluid pump (5) pressurizes a dose of fluid (2) when dispensing or nebulizing the dose of fluid (2).

### Claim 19 (depends on 17)

The system according to claim 17, wherein the air pump (30) is actuated by a relative movement of the container (3) within a housing (1b) of the nebulizer (1), in particular wherein the container (3) is moveable preferably stroke-like in the nebulizer (1) when withdrawing a dose of fluid (2) and/or when pressurizing or dispensing a dose of the fluid (2).

### Claim 20 (depends on 17)

The system according to claim 17, wherein the air pump (30) comprises or forms a piston/cylinder arrangement for pumping air to help withdrawing the fluid (2) in doses from the container (3).

### Claim 21 (depends on 17)

The system according to claim 17, wherein the container (3) drives or forms a pump piston (31) of the air pump (30), preferably cooperating with or moveable in a preferably detachable housing part (18) or an associated cylinder (32) or insert (33).

### Claim 22 (depends on 17)

The system according to claim 17, wherein the nebulizer (1) or air pump (30) comprises an inlet valve (44) preventing any underpressure in the air pump (30) or its pump chamber (39).

### Claim 23 (depends on 1)

The system according to claim 1, wherein the nebulizer (1) operates purely mechanically.

### Claim 24 (depends on 1)

The system according to claim 1, wherein the nebulizer (1) is a hand-held device and/or a portable device.

### Claim 25 (depends on 1)

The system according to claim 1, wherein the nebulizer (1) is an inhaler.

### Claim 26 (depends on 1)

The system according to claim 1, wherein the nebulizer (1) is a device for ophthalmological application of the fluid (2).

### Claim 27 (depends on 1)

The system according to claim 1, wherein the fluid (2) is fabricated/produced from at least two components and wherein the container (3) comprises at least two chambers/inner volumes each containing one of the at least two components, wherein the fluid (2) is fabricated/produced by combining/mixing the two components within the container (3).

### Claim 28

A method, comprising:
nebulizing a fluid (2) with a nebulizer 1, wherein the nebulizer (1) comprises a fluid pump (5) for withdrawing a dose of the fluid (2) from a container (3) and pressing a respective dose with an operational pressure of one of: (i) 5 to 250 MPa, (ii) 10 to 50 MPa, through a nozzle (12) with at least one nozzle channel (12d), having a hydraulic diameter in the range of one of: (i) 3 to 20 microns, (ii) 4 to 12 microns, and (iii) 5 to 8 microns,
wherein the fluid (2) is fabricated and/or produced from at least two components,
wherein the at least two components are stored within at least two initially fluidically separate chambers and/or inner volumes in a container (3), each chamber and/or inner volume containing one of the at least two components, and
wherein the chambers and/or inner volumes are fluidically connected, so that at least one of the components is at least partly transferred into the other and/or into one of the other chambers, so that the at least two components are mixed and/or combined for fabricating and/or producing and/or generating the fluid (2).

### Claim 29 (depends on 28)

The method according to claim 28, wherein the fluid is fabricated and/or generated/produced before the container (3) is fluidically connected to the nebulizer (1) for nebulizing the fluid (2).

### Claim 30 (depends on 28)

The method according to claim 28, wherein the fluid (2) is a liposomal fluid.

### Claim 31 (depends on 30)

The method according to claim 30, wherein the liposomal fluid is produced from at least a first component which comprises lecithin or dipalmitoylphosphatidylcholin (DPPC) and a second component comprising a carrier liquid, in particular an aqueous solution.

### Claim 32 (depends on 30)

The method according to claim 30, wherein the liposomal fluid is produced from at least a first component which is solid during storage, preferably in form of a powder and/or, particularly preferable, freeze-dried or lyophilized particles, and a second component which is a liquid.
